Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Prediction of insulin-dependent diabetes mellitus (IDDM) is still largely based on islet cell antibodies (ICAs), but it may be improved by combined analysis with other humoral markers. We examined autoantibodies to insulin (IAAs), glutamic acid decarboxylase (GAD), and Mr 37,000 and Mr 40,000 fragments of islet antigens (37 and 40 kDa) together with ICA subtypes in 101 family members with ICAs ≥10 Juvenile Diabetes Foundation units (JDF U) followed for up to 14 years, of whom 18 have developed IDDM. Life-table analysis showed a 43% risk of IDDM within 10 years for those with ICAs ≥10 JDF U, rising to 53% for those with ICAs ≥20 JDF U. The risk for ICAs ≥10 JDF U was 62% in the family members in the youngest age quartile (<13.2 years) and fell with increasing age to 4% in those >40.7 years of age (P = 0.03). ICAs ≥10 JDF U combined with IAAs gave a risk of 84% (P = 0.03 compared with IAA−), and ICAs ≥10 JDF U combined with GAD antibodies gave a risk of 61% (P = 0.018). The risk for ICAs >10 JDF U with antibodies to 37-kDa antigen was 76% (P < 0.0001). Risk increased with the number of autoantibodies, from 8% for ICAs alone to 88% with >3 autoantibodies (14 cases detected) (P < 0.0001). The increased risk associated with multiple antibodies was observed independent of age. The median time to diagnosis in those with antibodies to 37- and/or 40-kDa antigen was 1.5 years, compared with 7.2 years in those with IAAs and GAD antibodies in the absence of antibodies to 37/40 kDa. The intensity and range of the autoantibody response offers better overall prediction of diabetes than any single autoantibody specificity, although antibodies to 37-/40-kDa antigens may prove to be useful markers of early clinical onset. We found that 78% of future cases of IDDM in ICA+ relatives came from the 27% with multiple autoantibodies and estimate that 88% of individuals within this category will need insulin treatment within 10 years. We propose a simple predictive strategy based on these observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Baekkeskov, S., Aanstoot, H.-J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Oleson, H., & Camilli, P. D. (1990) · Nature · doi:10.1038/347782a0 · Cited by 352
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
Bonifacio, E., Shattock, M., Dean, B. M., Bottazzo, G. F., Bingley, P. M., Gale, E. A. M., & Dunger, D. (1990) · The Lancet · doi:10.1016/0140-6736(90)90013-u · Cited by 345
Self-citationRiley, W. J., Maclaren, N. K., Krischer, J., Spillar, R. P., Silverstein, J. H., Schatz, D. A., Schwartz, S., Malone, J., Shah, S., Vadheim, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010253231704 · Cited by 287
Franco Bottazzo, G. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91167-8 · Cited by 278
Bottazzo, G. F., & Gleichmann, H. (1986) · Diabetologia · doi:10.1007/bf00456124 · Cited by 143
Self-citationZiegler, A. G., Ziegler, R., Vardi, P., Jackson, R. A., Soeldner, J. S., & Eisenbarth, G. S. (1989) · Diabetes · doi:10.2337/diab.38.10.1320 · Cited by 140
Bingley, P. J., Bonifacio, E., & Gale, E. A. M. (1993) · Diabetes · doi:10.2337/diab.42.2.213 · Cited by 136
Self-citationVardi, P., Crisa, L., Jackson, R. A., Dumont Herskowitz, R., Wolfsdorf, J. I., Einhorn, D., Linarelli, L., Dolinar, R., Wentworth, S., Brink, S. J., et al. (1991) · Diabetologia · doi:10.1007/bf00500379 · Cited by 122
Genovese, S., Bonifacio, E. E., McNally, J. M., Dean, B. M., Wagner, R., Bosi, E., Gale, E. A. M., & Bottazzo, G. F. (1992) · Diabetologia · doi:10.1007/bf00401207 · Cited by 113
Self-citationGianani, R., Pugliese, A., Bonner‐Weir, S., Shiffrin, A. J., Soeldner, J. S., Erlich, H., Awdeh, Z., Alper, C. A., Jackson, R. A., & Eisenbarth, G. S. (1992) · Diabetes · doi:10.2337/diab.41.3.347 · Cited by 113
Christie, M. R., Vohra, G., Champagne, P. S., Daneman, D., & Delovitch, T. L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.3.789 · Cited by 112
Self-citationSerum exchange and use of dilutions have improved precision of measurement of islet cell antibodies
Bonifacio, E. E., Lernmark, Å., & Dawkins, R. L. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90274-8 · Cited by 107
Self-citationIslet cell antigens in insulin-dependent diabetes: Pandora's box revisited
Harrison, L. C. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90170-c · Cited by 96
Christie, M. R., Tun, R. Y. M., Lo, S. S. S., Cassidy, D., Brown, T. J., Hollands, J., Shattock, M., Bottazzo, G. F., & Leslie, R. D. G. (1992) · Diabetes · doi:10.2337/diab.41.7.782 · Cited by 96
Self-citationCan Islet Cell Antibodies Predict IDDM in the General Population?
Bingley, P. J., Bonifacio, E., Shattock, M., Gillmor, H. A., Sawtell, P. A., Dunger, D. B., Scott, R. D. M., Bottazzo, G. F., & Gale, E. A. M. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.45 · Cited by 89
Self-citationChristie, M. R., Hollands, J., Brown, T. J., Michelsen, B. K., & Delovitch, T. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116556 · Cited by 76
Self-citationChristie, M. R., Brown, T. J., & Cassidy, D. (1992) · Diabetologia · doi:10.1007/bf00401206 · Cited by 48
Self-citationThe determination of detection limits for insulin antibody assays
Kurtz, A. B., Silvio, L. D., & Bosi, E. (1988) · Diabetologia · doi:10.1007/bf02341510 · Cited by 17
Cited by
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, H. P., Eisenbarth, G. S., & Jackson, R. A. (1996) · Diabetes · doi:10.2337/diab.45.7.926 · Cited by 827
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
Self-citation
Metadata
- Authors
- Bingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1994-11-01
- Volume
- 43
- Issue
- 11
- Pages
- 1304-1310
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111625815
- Cited by
- 389
- References
- 19
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.